Write the number that best describes your erectile function for the past 4 weeks in the spaces provided

Over the past four weeks:
1. How often were you able to get an erection during sexual activity? __________

0 = No sexual activity
1 = Almost never/never
2 = A few times (much less than half the time)
3 = Sometimes (about half the time)
4 = Most times (much more than half the time)
5 = Almost always/always

2. When you had erections with sexual stimulation, how often were your erections hard enough for penetration? __________

0 = No sexual activity
1 = Almost never/never
2 = A few times (much less than half the time)
3 = Sometimes (about half the time)
4 = Most times (much more than half the time)
5 = Almost always/always

3. When you attempted sexual intercourse, how often were you able to penetrate (enter) your partner? __________

0 = Did not attempt intercourse
1 = Almost never/never
2 = A few times (much less than half the time)
3 = Sometimes (about half the time)
4 = Most times (much more than half the time)
5 = Almost always/always

4. During intercourse, how often were you able to maintain your erection after you had penetrated (entered) your partner? __________

0 = Did not attempt intercourse
1 = Almost never/never
2 = A few times (much less than half the time)
3 = Sometimes (about half the time)
4 = Most times (much more than half the time)
5 = Almost always/always

5. During sexual intercourse, how difficult was it to maintain your erection to completion of intercourse? __________

0 = Did not attempt intercourse
1 = Extremely difficult
2 = Very difficult
3 = Difficult
4 = Slightly difficult
5 = Not difficult

15. How would you rate your confidence that you could get and keep an erection? __________

1 = Very low
2 = Low
3 = Moderate
4 = High
5 = Very high

Score

Interpretation

1-10

Severe dysfunction

11-16

Moderate dysfunction

17-21

Mild to moderate dysfunction

22-25

Mild dysfunction

26-30

No ED

The International Index of Erectile Function (IIEF): a state-of-the-science review

R C Rosen¹, J C Cappelleri² and N Gendrano III¹

¹Department of Psychiatry, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway, New Jersey, USA

²Pfizer Inc, Global Research and Development, Groton, Connecticut, USA